High-dose IL-2 and IL-15 enhance the in vitro priming of naive CD4+ T cells for IFN-γ but have differential effects on priming for IL-4

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2413-2422

  Seder, Robert A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; FEMALE; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOCHROME C GROUP; DRUG SYNERGISM; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKINS; L-SELECTIN; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; TH1 CELLS;

EID: 0029940629     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Sher, A., and R. L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385.
2. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34.
3. Scott, P., and S. H. E. Kaufmann. 1991. The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today 12:346.
4. Urban, J. P., K. B. Madden, A. Svetic, A. Cheever, P. P. Trotta, W. C. Cause, I. M. Katona, and F. D. Finkelman. 1992. The importance of Th2 cytokines in protective immunity to nematodes. Immunol. Rev. 127:205.
5. Parish, C. R., and F. Y. Liew. 1972. Immune response to chemically modified flagellin. in. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J. Exp. Med. 135:298.
6. Parish, C. R. 1972. The relationship between humoral and cell-mediated immunity. Transplan. Rev. 13:35.
7. Bretscher, P. A., G. Wei, J. N. Menon, and O. H. Bielefeldt. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539.
8. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
9. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weirier, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 80:707.
10. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
11. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
12. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
13. LeGros, G. G., S. S. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:920.
14. Hsieh, C. S., A. B. Heimberger, J. S. Gold, A. O'Garra, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukin 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89: 6065.
15. + T cells to enhance priming for Interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 290:10188.
16. Powers, G. D., A. K. Abbas, and R. A. Miller. 1988. Frequencies of IL-2- and IL-4-secreting T cells in naive and antigen-stimulated lymphocyte populations. J. Immunol. 140:3352.
17. Ben-Sasson, S. S., G. G. LeGros, D. H. Conrad, F. D. Finkelman, and W. E. Paul. 1990. IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production. J. Immunol. 145:1127.
18. Heinzel, F. P., R. M. Rerko, F. Hatam, and R. M. Locksley. 1993. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J. Immunol. 150:3924.
19. Schorle, H., T. Koltschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621.
20. Sadlack, B., R. Kuhn, H. Schorle, K. Rajewsky, W. Muller, and I. Horak. 1994. Development and proliferation of lymphocytes' in mice deficient for both interleukin-2 and -4. Eur. J. Immunol. 14:281.
21. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, L. Johnson, M. R. Alderson, J. D. Watson, D. M. Anderson, and J. G. Giri. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965.
22. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395.
23. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the ß and γ chains of theIL-2 receptor by the novel cytokine IL-15.EMBO J. 13:2822.
24. Ohara, J., and W. E. Paul. 1985. B cell stimulatory factor (BSF-1): production of a monoclonal antibody and molecular characterization. Nature 315:333.
25. Cherwinski, H., J. Schumacher, K. Brown, and T. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally, monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
26. Fink, P., W. Gallatin, R. Reichert, E. Butcher, and I. Weissman, 1985. Homing receptor-bearing thymocytes, an immunocompetent cortical subpopulation. Nature 313:233.
27. Mosmann, T., H. Cherwinski, M. Bond, M. Giedlin, and R. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
28. Ortega, G., R. Robb, E. Shevach, and T. Malek. 1984. The murine IL-2 receptor. J. Immunol. 133:1970.
29. Tanaka, T. 1991. A novel monoclonal antibody against murine IL-2 receptor β chain. J. Immunol. 147:2222.
30. Seder, R. A., R. N. Germain, P. S. Linsley, and W. E. Paul. 1994. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J. Exp. Med. 179:299.
31. Gately, M. K., B. B. Desai, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, F. J. Podlaski, P. C. Familletti, F. Sinigaglia, R. Chizonnite, U. Gubler, and A. S. Stem. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874.
32. Hsieh, C.-S., S. E. Macatonia, A. O'Garra, and K. M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713.
33. + T cells. Annu. Rev. Immunol. 12:635.
34. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. L. Simard, P. S. Ohashi, H. Griesser, T. Taniguchi, C. J. Paige, and T. W. Mak. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268:1472.
35. Kasahara, T., J. J. Hooks, S. F. Dougherty, and J. J. Oppenheim. 1983. Interleukin 2-mediated immune interferon (IFN-γ) production by human T cells and T cell subsets. J. Immunol. 130:1784.
36. Vilcek, J., D. Henriksen-Destefamp, D. Siegel, A. Klion, R. J. Robb, and J. Le. 1985. Regulation of EFN-γ induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2. J. Immunol. 135:1851.
37. Farrar, W. L., M. C. Birchenall-Sparks, and H. B. Young. 1986. Interleukin 2 induction of interferon-γ mRNA synthesis. J. Immunol. 137:3836.
38. Lin, J., T. S. Migone, M. Tsang, M. Friedman, J. A, Weatherbee, L. Zhou, A. Yamauchi, E. T. Bloom, J. Mietz, S. John, and W. J. Leonard. 1995. The role of shared receptor motifs and common stat proteins in the generation of cytokine pleitropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331.
39. Ihle, J. N., B. A. Witthuhn, F. W. Quelle, K. Yamamoto, W. E. Thierfelder, B. Krieder, and O. Silvennoinen. 1994. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 19:222.
40. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. EL-4 and IFNγ direct the development of distinct subsets of helper T cells. Fed. Proc. 4:2020.
41. + αβ-TCR transgenic T cells is macrophage dependent. Int. Immunol. 5:371.
42. + T cells from αβ-TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-dependent. Int. Immunol. 5:1119.
43. + T cell response. J. Exp. Med. 181:961.
44. Schijns, V. E. C., B. L. Haagmans, E. O. Rijke, S. Huang, M. Aguet, and M. C. Horzinek. 1994. IFN-γ receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J. Immunol. 153:2029.
45. + effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J. Exp. Med. 179:1367.
46. Kundig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262:1059.
47. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. F. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
48. Bendelac, A., P. Matzinger, R. A. Seder, W. E. Paul, and R. H. Schwartz. 1992. Activation events during thymic selection. J. Exp. Med. 175:731.
49. Lenardo, M. J. 1991. Interleukin-2 programs mature αβ T cells for apoptosis. Nature 353:858.
50. Rosenberg, S. A., M. T. Lotze, L. M. Muul, S. Leitman, A. E. Chang, S. E. Ettinghausen, Y. L. Matory, J. M. Skibber, E. Shiloni, J. T. Vetto, C. A. Seipp, C. Simpson, and C. M. Reichert. 1985. Special Report: observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 313:1485.
51. + T lymphocytes in HIV-infected patients with intermittent continuous infusion interleukin-2 therapy: a preliminary report. N. Engl. J. Med. 332:567.
52. Seder, R. A., K. H. Grabstein, J. A. Berzofsky, and J. F. McDyer. 1995. Cytokine interactions in HIV-infected individuals: roles of EL-2, IL-12, and IL-15. J. Exp. Med. 182:1067.